SCHEMBL5091289

SCHEMBL5091289

NC(=O)[AsH]Cc1cccc(Nc2nc(Nc3ccc(S(N)(=O)=O)cc3)ncc2F)c1

nearest known ligand 0.57

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SYK P43405 8/20 0.57
AURKA O14965 4/20 0.55
AURKB Q96GD4 4/20 0.55
NTRK1 P04629 3/20 0.53
JAK2 O60674 3/20 0.53
CDK2 P24941 6/20 0.52
CCNA2 P20248 2/20 0.52
JAK3 P52333 3/20 0.51
JAK1 P23458 1/20 0.51
EGFR P00533 4/20 0.50
ITK Q08881 4/20 0.50
KDR P35968 3/20 0.50
GSK3A P49840 3/20 0.50
GSK3B P49841 3/20 0.50
PLK4 O00444 2/20 0.50
PDPK1 O15530 2/20 0.50
DAPK3 O43293 2/20 0.50
MAP4K4 O95819 2/20 0.50
PAK4 O96013 2/20 0.50
CHEK2 O96017 2/20 0.50

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4003164 0.87 NTRK1 (0.58) SYKAURKAAURKBNTRK1JAK2
SCHEMBL4007702 0.82 NTRK1 (0.54) SYKAURKAAURKBNTRK1JAK2
SCHEMBL4005181 0.81 NTRK1 (0.54) SYKAURKAAURKBNTRK1JAK2
SCHEMBL4975656 0.81 NTRK1 (0.58) SYKAURKAAURKBNTRK1JAK2
SCHEMBL4006056 0.81 SYK (0.70) SYKAURKAAURKBNTRK1JAK2
SCHEMBL2477119 0.81 NTRK1 (0.57) SYKAURKAAURKBNTRK1JAK2
SCHEMBL4007740 0.80 NTRK1 (0.60) SYKAURKAAURKBNTRK1JAK2
SCHEMBL4970415 0.80 AURKA (0.55) SYKAURKAAURKBNTRK1JAK2
SCHEMBL3998520 0.80 JAK3 (0.58) SYKAURKAAURKBNTRK1JAK2
SCHEMBL4972409 0.79 NTRK1 (0.55) SYKAURKAAURKBNTRK1JAK2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1904457-A2 COMPOSITIONS AND METHODS FOR INHIBITION OF THE JAK PATHWAY Rigel Pharmaceuticals, Inc. (US) 2008-04-02 EP disclosed
WO-2006133426-A2 COMPOSITIONS AND METHODS FOR INHIBITION OF THE JAK PATHWAY RIGEL PHARMACEUTICALS, INC. (US) 2006-12-14 WO disclosed